4.5 Letter

Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Differential diagnosis and prospective grading of COVID-19 at the early stage with simple hematological and biochemical variables

Lin Song et al.

Summary: The study evaluated simple laboratory variables for distinguishing COVID-19 from bacterial pneumonia or influenza and for grading COVID-19. Specific indicators such as leukocytosis and decreased lymphocyte-to-monocyte ratio were found to be helpful in distinguishing different respiratory diseases, aiding in rapid diagnosis and management.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)

Article Allergy

Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

Isabelle Meyts et al.

Summary: The study shows that patients with IEI exhibit varied responses to SARS-CoV-2 infection, with some requiring hospitalization and even intensive care, and a non-negligible mortality rate. In comparison to the general population, younger IEI patients may face a higher risk of severe illness and mortality.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Letter Allergy

Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City

Hsi-en Ho et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Allergy

A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia

Isabella Quinti et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Editorial Material Medicine, General & Internal

Covid-19: risk factors for severe disease and death

Rachel E. Jordan et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Multidisciplinary Sciences

Substantial underestimation of SARS-CoV-2 infection in the United States

Sean L. Wu et al.

NATURE COMMUNICATIONS (2020)

Letter Medicine, General & Internal

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Bina Choi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)